Morgan Stanley Call 30 VNA 19.12..../ DE000MG20F74 /
28/05/2024 8:55:00 | Diferencia0.000 | Bid13:23:26 | Ask13:23:26 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
0.390EUR | 0.00% | 0.430 Volumen de oferta: 250,000 |
0.440 Tamaño/ Volumen/ Formato de Ask: 250,000 |
VONOVIA SE NA O.N. | 30.00 EUR | 19/12/2025 | Call |
GlobeNewswire
14:53
InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. In...
GlobeNewswire
14:45
Wearable Devices XR Team's Report: The Mudra’s Neural Technology to Power Future XR Devices
GlobeNewswire
14:45
Aprea Therapeutics Announces that Safety Review Committee (SRC) Endorses Dosing of Patients with ATR...
GlobeNewswire
14:40
AITX’s RAD Announces First Paid Analytic based on Vast Improvements in Its Firearm Detection Speed &...
GlobeNewswire
14:39
Specialized Education Services, Inc. Unveils 2024 Staff and Teacher of the Year Winners
GlobeNewswire
14:31
Mama’s Creations to Host First Quarter and Fiscal Year 2025 Earnings Call on June 11 at 4:30 p.m. Ea...
GlobeNewswire
14:30
Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Press...
GlobeNewswire
14:30
Nano Dimension Is Partnering with Esko and Fiery to Provide an End-To-End Industry 4.0 Solution
GlobeNewswire
14:30
SRIVARU (SVMH) Announces the Completion of State-of-the-Art Factory and Fully Automated EV Motorcycl...
GlobeNewswire
14:30
GunBroker Partners with Gearfire Capital to Offer Innovative Financing Solutions for Firearms Retail...
GlobeNewswire
14:30
Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Dist...
GlobeNewswire
14:30
NewGenIvf Receives Nasdaq Notifications Regarding Market Value of Publicly Held Shares and Market Va...
GlobeNewswire
14:30
Golden Triangle Ventures, Inc. Announces Strategic Agreement with T&K Zarro, LLC to Strengthen Capit...
GlobeNewswire
14:30
Lisata Therapeutics to Participate in Upcoming June 2024 Industry and Investor Events
GlobeNewswire
14:30
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depre...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página